|
|
||||||||
|
FIGURE 5. The plots for the images in Figure 4 show the time course of 18F-FDG SUV changes in tumor, brain, and gray matter. SUV is highest in tumor and remains so over the course of the study. Brain tissue and gray matter SUVs decline at later times.
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |